AUTOIMMUNE DISEASES STATISTICAL & CLINICAL COORDINATING CENTER (AD-SCCC)
NIAID/DAIT intends a sole-source contract modification with Rho Federal Systems Division to extend the existing Autoimmune Diseases Statistical & Clinical Coordinating Center (AD-SCCC) for two option periods. Performance is anticipated from February 1, 2027 through January 31, 2028, with an additional six-month option through July 31, 2028, and an anticipated award date of February 1, 2027. The current contract has a total value of $49,268,667 and is a term/level-of-effort contract for 56,170 direct labor hours per year. The AD-SCCC provides statistical design and analysis, protocol development, study initiation and management, data management and reporting, clinical safety and pharmacovigilance, safety oversight, collaboration portals, manuscript support, and specimen repository services for NIAID-supported autoimmune disease and related clinical research. This is not a request for competitive proposals, though responsible sources may express interest by capability statement for the government to consider whether to compete.